))
Additional Advances in Plaque Psoriasis Clinical Trials and Research With Steven Feldman, MD, PhD
Manage episode 475088433 series 3456244
Content provided by i3 Health and I3 Health. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by i3 Health and I3 Health or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Plaque psoriasis is more than just a skin condition—it’s a chronic, immune-mediated disorder that can deeply affect a person’s quality of life. That’s why it’s essential for healthcare professionals to develop effective patient education strategies that address safety concerns, improve communication, and encourage therapy adherence. In this episode, we’re joined by Dr. Steven Feldman, a renowned Professor of Dermatology, Pathology, and Social Sciences & Health Policy at Wake Forest University School of Medicine. Dr. Feldman, who is leading i3 Health’s CME/NCPD/CPE activity Patient Point of View: PDE4 Inhibitors for the Treatment of Adult Plaque Psoriasis, dives into the latest breakthroughs in plaque psoriasis research and shares his expert insights on how these advancements are shaping patient care. Don’t miss this opportunity to expand your knowledge and improve your practice! After listening, be sure to complete the full activity to deepen your understanding and apply what you’ve learned. Click the link below to access the full CME/NCPD/CPE activity! Link to the Activity: https://bit.ly/4hW9ozG
…
continue reading
64 episodes
Share
